BVF PARTNERS L P/IL - Director, Other*, 10%+ Owner at CTI BIOPHARMA CORP

Issuer-level insider activity

Role
Director, Other*, 10%+ Owner
Issuer ticker
CTIC
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by BVF PARTNERS L P/IL since 20 Aug 2025

Reported holdings for BVF PARTNERS L P/IL in CTI BIOPHARMA CORP

Form 4 holding Director, Other*, 10%+ Owner

CTI BIOPHARMA CORP

Security class
Common Stock, par value $0.001
Shares / value
0
Estimated value
Report date
26 Jun 2023
Price
$9.10
Ownership
Direct
Form 4 holding Director, Other*, 10%+ Owner

CTI BIOPHARMA CORP

Security class
Common Stock, par value $0.001
Shares / value
0
Estimated value
Report date
26 Jun 2023
Price
$9.10
Ownership
Indirect
Form 4 holding Director, Other*, 10%+ Owner

CTI BIOPHARMA CORP

Security class
Series X1 Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
26 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.001
Underlying amount
Form 4 holding Director, Other*, 10%+ Owner

CTI BIOPHARMA CORP

Security class
Series X Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
26 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.001
Underlying amount
1,910,000
Form 4 holding Director, Other*, 10%+ Owner

CTI BIOPHARMA CORP

Security class
Series X Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
26 Jun 2023
Price
Ownership
Indirect
Underlying class
Common Stock, par value $0.001
Underlying amount
120,000
Form 4 holding Director, Other*, 10%+ Owner

CTI BIOPHARMA CORP

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
26 Jun 2023
Price
Ownership
Indirect
Underlying class
Common Stock, par value $0.001
Underlying amount

Transaction history for BVF PARTNERS L P/IL in CTI BIOPHARMA CORP

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .